What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.
submitter:
Giuseppe BRUNO
email submitter:
giuseppe.bruno@uniroma1.it
Contributors:
Reed C1
Happich M2
Argimon Jm3
Haro Jm4
Wimo A5
6
Bruno Giuseppe
Dodel R8
Jones Rw9
Vellas B10
Author information 1 Eli Lilly Belger M. 1.
Company Limited
Lilly Research Centre
Windlesham
2 Lilly Deutschland GmbH U. K.
Bad Homburg
3 Divisió d'avaluació G. e. r. m. a. n. y.
Servei Català de la Salut
Barcelona
4 Parc Santari Sant Joan de Déu S. p. a. i. n.
Cibersam
Universitat de Barcelona
Sant Boi de Llobregat
Barcelona
5 KI Division of Neurogeriatrics S. p. a. i. n.
Department of Neurobiology
Care Sciences
Society
Karolinska Institute
Stockholm
6 Centre for Research S. w. e. d. e. n.
Development
Uppsala University/Region of Gavleborg
Gävle
7 Clinica della Memoria S. w. e. d. e. n.
Department of Neurology
Psychiatry
University of Rome Sapienza
Rome
8 Department of Neurology I. t. a. l. y.
Philipps University
Marburg
9 RICE G. e. r. m. a. n. y.
>The RICE Centre
Royal United Hospital
Bath
10 Gerontopole U. K.
Alzheimer's Disease Research
Clinical Care
Inserm 1027
Toulouse University Hospital
Toulouse France
Rivista:
JOURNAL OF ALZHEIMER'S DISEASE
Anno:
2017
issn:
1387-2877
doi:
10.3233/JAD-160449
volume:
3
pagina inizio:
797
pagina fine:
812
handle:
11573/999534
itemId:
595820
tipo pubblicazione:
01a Articolo in rivista
esposizione:
no
tipo pubblicazione iris:
issue:
57
esposizione personale:
no